CIDP Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Condition:   Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Intervention:   Sponsors:   Takeda;   Baxalta Innovations GmbH, now part of Shire;   RTI Health Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials